LINC Newsflash: 'Premium Expansion' with Directional Scoring Balloon Redefines Peripheral Vascular Preparation
DK Medtech
Vascular Interventional Balloon Product Developer
“DKutting LL can be our new work-horse balloon for every kind of peripheral lesion.” --Lorenzo Patrone
DKutting LL Directional Scoring Balloon is our new main balloon for handling various peripheral vascular lesions.
On January 28, 2026, at LINC (the top academic conference in the field of peripheral vascular intervention), Dr. Lorenzo Patrone will present DK Medtech's third-generation peripheral directional scoring balloon dilation catheter, DKutting™ LL. He is scheduled to report single-center early clinical data and application experience at 10:30 AM (German local time) on the 29th. The product has received EU CE MDR (Certificate No. 816124) and US FDA 510(k) (No. K242254) approval. It is specifically designed for peripheral vascular lesions such as iliac, femoral, and popliteal arteries. With innovative technology breaking through traditional treatment limitations, it is expected to become a first-line treatment tool for complex peripheral lesions.
Core Highlight Technology｜Precision. Power. Control. Balancing Efficacy and Safety
Swipe left and right to view
Experts Strongly Recommend｜Expected to Become the "Main Balloon" for Complex Lesions
Dr. Lorenzo Patrone from San Giovanni di Dio Hospital in Florence, Italy, will share clinical experience with 20 cases at the LINC conference, praising DKutting™ LL as "the new go-to balloon for various peripheral lesions." He noted that while traditional balloon angioplasty (POBA) remains the gold standard for treating vessels below the femoropopliteal region, it has limitations such as a high rate of lesion recurrence and uncontrollable vascular expansion. The nickel-titanium coil triangular cutting design of DKutting™ LL achieves "orderly tearing and controlled injury," avoiding the chaotic tearing associated with traditional balloons at lower pressures, while allowing precise vessel expansion through moderate pressurization when needed. This creates an optimal foundation for subsequent treatments, such as reducing stent placement and optimizing drug-loading for drug-coated devices.
Industry Significance｜A New Era in the Treatment of Refractory Lesions
DKutting™ LL, with its focused pressure delivery, precise controllable expansion, and excellent passability, successfully overcomes the treatment bottleneck of traditional balloons in complex, long-segment peripheral lesions. Its design balances efficacy, safety, and convenience, providing clinicians with a more reliable vascular preparation tool and potentially reducing the target lesion revascularization rate, offering long-term benefits to patients with peripheral vascular disease. Covering full peripheral vascular treatment scenarios from iliac arteries to tibial arteries, this product will become an important innovative force in the field of peripheral interventions.
